Acambis plc, of Cambridge, UK, announced results of a Phase I trial of its modified vaccinia Ankara smallpox vaccine, MVA3000, in 88 healthy adults who had not been vaccinated against smallpox previously. A comparator group of 22 …
No comments:
Post a Comment